Christopher G Armstrong

Title: Christopher G Armstrong: Innovator in Pharmaceutical Compositions

Introduction

Christopher G Armstrong is a notable inventor based in Madison, WI (US). He has made significant contributions to the field of pharmaceuticals, particularly in developing methods to counteract the cardiotoxic effects of chemotherapy. With a total of 4 patents to his name, Armstrong's work is pivotal in enhancing cancer treatment outcomes.

Latest Patents

Armstrong's latest patents focus on pharmaceutical compositions and methods for reducing or eliminating chemotherapy-induced cardiotoxicity. These disclosures provide innovative methods and compositions aimed at mitigating cardiotoxicity, especially that which is induced by cancer treatments. The methods often involve administering protective agents such as myricetin, tricetin, robinetin, ficetin, vitexin, quercetin, dihydrorobinetin, kaempferol, and others in conjunction with cancer drugs. The compositions may also include co-formulations of protective agents with anthracycline drugs, showcasing Armstrong's commitment to improving patient care during cancer therapies.

Career Highlights

Throughout his career, Armstrong has worked with various companies, including Auransa Inc. and Sct II LLC. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and the development of effective treatment methods.

Collaborations

Armstrong has collaborated with notable colleagues such as Kevin J Kim and Lisa Maria Lucia Pham. These partnerships have likely enriched his research and development efforts, leading to advancements in the pharmaceutical field.

Conclusion

Christopher G Armstrong is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly improve the quality of life for cancer patients. His innovative approaches to countering chemotherapy-induced cardiotoxicity reflect his dedication to advancing medical science.